Canopy Growth Corp.: Is it Wise to Buy This Stock Today?

Canopy Growth Corp. (TSX:WEED) is the leader in a rapidly expanding market. Should you own this stock?

| More on:

Canopy Growth Corp. (TSX:WEED) has captured the imagination of retail investors across Canada.

The company is one of the most popular stocks on the TSX, and despite some serious volatility in recent months, it continues to attract investors hoping to cash in on the growing marijuana segment.

Let’s take a look at the current situation to see if the stock should be in your portfolio.

Positive developments

Canopy is making all the right moves to ensure it retains its leadership position in the Canadian medical marijuana market.

The company recently closed its acquisition of competitor Mettrum Health Corp. in a move that adds two national brands to the portfolio and expands production capabilities. It also increases Canopy’s customer base to the point where it provides product to about half the registered patients in the Canadian medical marijuana market.

Ramping up production capacity is important in this fast-paced segment, so Canopy has entered an agreement with a real estate company, the Goldman Group, to help it grow.

Goldman will buy or build facilities and outfit them to meet Canopy’s production requirements. Canopy will then lease the locations from Goldman.

The latest strategic move is a memorandum of understanding (MOU) with Namaste Technologies, which is a provider of cannabis accessories through its e-commerce retail stores.

Canopy also has a partnership in Brazil and owns a pharmaceutical distributor in Germany.

Overall, things are rolling along quite well.

Canopy just released results for the quarter ended December 31, 2016. Revenue came in at $9.75 million — up 15% from the previous quarter and 180% higher than the same period in 2015.

Risks

At the time of writing, Canopy has a market capitalization of more than $2 billion. That’s a lot for a business with quarterly revenue of less than $10 million.

Investors are betting that Ottawa will follow through on plans to legalize the recreational cannabis market in the near future.

The government received an initial report from its task force at the end of November and is expected to table legislation in the coming months. If all goes according to the hopes of Canopy’s investors, legal marijuana might be available in 2018.

As the industry leader, Canopy stands to capture a fair chunk of that market, which is estimated at $5 billion per year or better.

So, it’s easy to see why investors are so hungry for the stock, but there are big downside risks if Ottawa’s plans hit a speed bump.

A number of technical issues could hold up the process, including the decision on how to tax the product. Too much tax could simply drive consumers to the black market; not enough tax will make the proposition a losing venture for Ottawa and the provinces.

Another potential situation to watch is pushback from voters. Canadians might be open minded about allowing people to smoke pot in a legal framework, but that doesn’t mean they want dispensaries set up in their neighbourhoods.

If MPs start to get an earful from angry residents, and there are already indications of conflicts in areas where illegal dispensaries are currently in operation, the entire rollout could come to a screaming halt.

If that happens, Canopy’s investors could be in for a shock.

Should you buy?

The company is doing everything right at this point in the game, but the valuation is so high that investors are at serious risk if bad news come out of Ottawa.

As such, I would stay on the sidelines until there is more clarity on the legalization of the recreational market.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stocks mentioned.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »